Document Detail


Long acting nifedipine in the treatment of severe hypertension.
MedLine Citation:
PMID:  6386487     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The medication of patients receiving hydralazine, captopril and minoxidil was replaced by a new galenical form, long-acting nifedipine. An additional decrease in blood pressure was observed in most of the patients. Renal function was maintained in all of them. Adverse reactions may be reduced by the use of long-acting nifedipine, which would permit a reduction in the dosage of captopril and minoxidil.
Authors:
M Bursztyn; E Grossmann; T Rosenthal
Related Documents :
9543597 - A comparison of the safety and efficacy of mibefradil and nifedipine sr in patients wit...
811427 - Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable ...
3664537 - Effects of verapamil, nifedipine, and dilazep on left ventricular relaxation in the con...
2372167 - Supraventricular tachyarrhythmias and rate-related hypotension: cardiovascular effects ...
11069337 - Efficacy of the laryngeal tube during intermittent positive-pressure ventilation.
15471167 - Left atrial systolic function in primary and familial amyloidosis: assessment from left...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  27     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1984  
Date Detail:
Created Date:  1984-12-20     Completed Date:  1984-12-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  13-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Pressure
Female
Humans
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Nifedipine / administration & dosage,  adverse effects,  therapeutic use*
Renin / blood
Sodium / urine
Time Factors
Chemical
Reg. No./Substance:
21829-25-4/Nifedipine; 7440-23-5/Sodium; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
Next Document:  Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man.